Episode 101: Biotech Strategy and Creative Fundraising for Rare Disease Drug Development
How can biotech leaders navigate the complexities of neurodegenerative research while tackling today’s funding challenges?
In this episode, host Elaine Hamm, PhD, welcomes Vikas Sharma, PhD, Chief Business Officer at QurAlis, for an insightful conversation on innovation, leadership, and fundraising in the biotech sector. Drawing from his extensive experience with ALS and neurodegeneration research, Vikas shares lessons on balancing science with business, navigating board dynamics, and finding creative approaches to raise capital.
In this episode, you’ll discover:
- Why genetic insights are reshaping neurodegenerative research.
- How to creatively approach funding when investors are focused on lower-risk, later-stage opportunities.
- Practical strategies for balancing science, investors, and board relationships to drive biotech success.
Tune in to gain actionable strategies and leadership lessons that can help you move your biotech forward with confidence.
Links:
Connect with Vikas Sharma, PhD, and check out QurAlis.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Jason Adair, MBA, and Kevin Eggan, PhD.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU – the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
